Cargando…

Cellular Immune Responses for Squamous Cell Carcinoma Antigen Recognized by T Cells 3 in Patients with Hepatocellular Carcinoma

BACKGROUND & AIMS: Squamous cell carcinoma antigen recognized by T cells 3 (SART3), a tumor-associated antigen expressed in many cancers, functions in tumor rejection. In this study, we investigated its usefulness as an immunotherapeutic target in hepatocellular carcinoma (HCC). METHODS: The exp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaji, Kiichiro, Mizukoshi, Eishiro, Yamashita, Tatsuya, Arai, Kuniaki, Sunagozaka, Hajime, Fushimi, Kazumi, Nakagawa, Hidetoshi, Yamada, Kazutoshi, Terashima, Takeshi, Kitahara, Masaaki, Kaneko, Shuichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5256867/ https://www.ncbi.nlm.nih.gov/pubmed/28114424 http://dx.doi.org/10.1371/journal.pone.0170291

Ejemplares similares

Immune responses of human T lymphocytes to novel hepatitis B virus-derived peptides
por: Yamamiya, Daisuke, et al.
Publicado: (2018)

Light alcohol consumption has the potential to suppress hepatocellular injury and liver fibrosis in non-alcoholic fatty liver disease
por: Yamada, Kazutoshi, et al.
Publicado: (2018)

Peptide vaccine-treated, long-term surviving cancer patients harbor self-renewing tumor-specific CD8(+) T cells
por: Mizukoshi, Eishiro, et al.
Publicado: (2022)

Safety and Long-Term Outcome of Intratumoral Injection of OK432-Stimulated Dendritic Cells for Hepatocellular Carcinomas After Radiofrequency Ablation
por: Kitahara, Masaaki, et al.
Publicado: (2020)

A novel α-fetoprotein-derived helper T-lymphocyte epitope with strong immunogenicity in patients with hepatocellular carcinoma
por: Tamai, Toshikatsu, et al.
Publicado: (2020)

Overuse of antianaerobic drug is associated with poor postchemotherapy prognosis of patients with hepatocellular carcinoma
por: Iida, Noriho, et al.
Publicado: (2019)

Dickkopf-1 Promotes Angiogenesis and is a Biomarker for Hepatic Stem Cell-like Hepatocellular Carcinoma
por: Suda, Tsuyoshi, et al.
Publicado: (2022)

Serum cytokine profiles predict survival benefits in patients with advanced hepatocellular carcinoma treated with sorafenib: a retrospective cohort study
por: Hayashi, Tomoyuki, et al.
Publicado: (2017)

Adjuvant Alpha-Fetoprotein-Derived Peptide After Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma: Protocol for a Safety Study
por: Nomura, Akihiro, et al.
Publicado: (2020)

Response to chemotherapy improves hepatic reserve for patients with hepatocellular carcinoma and Child–Pugh B cirrhosis
por: Terashima, Takeshi, et al.
Publicado: (2016)

Potential efficacy of therapies targeting intrahepatic lesions after sorafenib treatment of patients with hepatocellular carcinoma
por: Terashima, Takeshi, et al.
Publicado: (2016)

Peretinoin, an acyclic retinoid, improves the hepatic gene signature of chronic hepatitis C following curative therapy of hepatocellular carcinoma
por: Honda, Masao, et al.
Publicado: (2013)

Immune cell therapy for hepatocellular carcinoma
por: Mizukoshi, Eishiro, et al.
Publicado: (2019)

Plasma Antithrombin III Levels Can Be a Prognostic Factor in Liver Cirrhosis Patients with Portal Vein Thrombosis
por: Suda, Tsuyoshi, et al.
Publicado: (2023)

Eradication of angiomas by nylon loop snare ligation under total enteroscopy, in disseminated intravascular coagulation associated with blue rubber bleb nevus syndrome
por: Nakagawa, Hidetoshi, et al.
Publicado: (2022)

Investigation of Thrombosis Volume, Anticoagulants, and Recurrence Factors in Portal Vein Thrombosis with Cirrhosis
por: Suda, Tsuyoshi, et al.
Publicado: (2020)

FOXM1 Is a Novel Molecular Target of AFP-Positive Hepatocellular Carcinoma Abrogated by Proteasome Inhibition
por: Li, Ru, et al.
Publicado: (2022)

Alterations in Hepatocellular Carcinoma-Specific Immune Responses Following Hepatitis C Virus Elimination by Direct-Acting Antivirals
por: Li, Shihui, et al.
Publicado: (2022)

Inactivation of Transcriptional Repressor Capicua Confers Sorafenib Resistance in Human Hepatocellular Carcinoma
por: Hashiba, Tomomi, et al.
Publicado: (2020)

Danaparoid sodium-based anticoagulation therapy for portal vein thrombosis in cirrhosis patients
por: Hayashi, Takehiro, et al.
Publicado: (2019)

Comprehensive and efficient analyses of T cell receptors for cancer antigens in peptide-vaccinated patients using a single cell-based gene cloning system
por: Nakagawa, Hidetoshi, et al.
Publicado: (2014)

BMP9‐ID1 signaling promotes EpCAM‐positive cancer stem cell properties in hepatocellular carcinoma
por: Chen, Han, et al.
Publicado: (2021)

Efficacy of a novel self-expandable metal stent with dumbbell-shaped flare ends for distal biliary obstruction due to unresectable pancreatic cancer
por: Miyazawa, Masaki, et al.
Publicado: (2022)

Effects of adaptive immune cell therapy on the immune cell profile in patients with advanced gastric cancer
por: Miura, Miyabi, et al.
Publicado: (2020)

Telomerase-Targeted Cancer Immunotherapy
por: Mizukoshi, Eishiro, et al.
Publicado: (2019)

Development of novel diagnostic system for pancreatic cancer, including early stages, measuring mRNA of whole blood cells
por: Sakai, Yoshio, et al.
Publicado: (2019)

Histological Course of Nonalcoholic Fatty Liver Disease in Japanese Patients: Tight glycemic control, rather than weight reduction, ameliorates liver fibrosis
por: Hamaguchi, Erika, et al.
Publicado: (2010)

Decline in serum albumin concentration is a predictor of serious events in nonalcoholic fatty liver disease
por: Kawaguchi, Kazunori, et al.
Publicado: (2021)

Management of biliary stricture in patients with IgG4-related sclerosing cholangitis
por: Miyazawa, Masaki, et al.
Publicado: (2020)

Upregulation of the Long Noncoding RNA HULC by Hepatitis C Virus and Its Regulation of Viral Replication
por: Kitabayashi, Juria, et al.
Publicado: (2020)

MicroRNA‐10a Impairs Liver Metabolism in Hepatitis C Virus‐Related Cirrhosis Through Deregulation of the Circadian Clock Gene Brain and Muscle Aryl Hydrocarbon Receptor Nuclear Translocator‐Like 1
por: Horii, Rika, et al.
Publicado: (2019)

Prognosis of type 1 autoimmune pancreatitis after corticosteroid therapy-induced remission in terms of relapse and diabetes mellitus
por: Miyazawa, Masaki, et al.
Publicado: (2017)

BMP9-ID1 Signaling Activates HIF-1α and VEGFA Expression to Promote Tumor Angiogenesis in Hepatocellular Carcinoma
por: Chen, Han, et al.
Publicado: (2022)

Comparison of Tofogliflozin and Glimepiride Effects on Nonalcoholic Fatty Liver Disease in Participants With Type 2 Diabetes: A Randomized, 48-Week, Open-Label, Active-Controlled Trial
por: Takeshita, Yumie, et al.
Publicado: (2022)

De Novo Emergence of Mesenchymal Stem-Like CD105(+) Cancer Cells by Cytotoxic Agents in Human Hepatocellular Carcinoma()()
por: Nomura, Yoshimoto, et al.
Publicado: (2017)

Sporadic PCDH18 somatic mutations in EpCAM-positive hepatocellular carcinoma
por: Hayashi, Takehiro, et al.
Publicado: (2017)

Characterization of adipose tissue-derived stromal cells of mice with nonalcoholic fatty liver disease and their use for liver repair
por: Yano, Masaaki, et al.
Publicado: (2021)

Hydroxynonenal Causes Hepatocyte Death by Disrupting Lysosomal Integrity in Nonalcoholic Steatohepatitis
por: Seike, Takuya, et al.
Publicado: (2022)

Sorafenib suppresses extrahepatic metastasis de novo in hepatocellular carcinoma through inhibition of mesenchymal cancer stem cells characterized by the expression of CD90
por: Yoshida, Mariko, et al.
Publicado: (2017)

Vegetable Oil-Peroxidation Product ‘Hydroxynonenal’ Causes Hepatocyte Injury and Steatosis via Hsp70.1 and BHMT Disorders in the Monkey Liver
por: Yamashima, Tetsumori, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9ui3gbs3o2vkc1mtg9mun828h6